What is Erlocip-150?
erlocip 150mg can be used along with other types of cancer treatments or other medications to treat pancreatic cancer and non small cell lung cancer that has spread to nearby tissues or to other parts of the body. The active ingredient erlotinib belongs to a class of medications called tyrosine kinase inhibitors. The medication works by interfering with the protein epidermal growth factor to prevent it from activating enzymes cancer cells require to multiply, grow and spread.
What is Erlocip used for?
erlocip are used to treat non-small cell lung cancer (NSCLC), which is the most common form of lung cancer and grows more slowly than small cell lung cancer (SCLC). NSCLC is associated with a mutation in the gene for Epidermal Growth Factor receptor (EGFR)1 and treatment of NSCLC with Erlocip tablets 150mg is only effective where an EGFR mutation is present in the tumour cells2.
Erlocip tablets 150mg are used for treatment of locally advanced (stage III) or metastatic (stage IV) NSCLC either as first-line treatment, as monotherapy maintenance treatment for stable disease after 4 cycles of standard platinum-based first-line chemotherapy or after failure of at least one prior chemotherapy regimen.
Erlocip tablets 150mg uses to treat locally advanced, unresectable (inoperable) or metastatic pancreatic cancer in combination with gemcitabine, an anti-cancer drug used for chemotherapy. Advanced pancreatic cancer has a very poor survival rate and Erlocip tablets 150mg in combination with gemcitabine can improve the survival rate.
How is Erlocip-150 used?
Erlocip 150mg should only be taken as directed by a doctor, usually once per day. The medication should be taken on an empty stomach with a glass of water at least 2 hours after or 1 hour prior to a meal. Contact a doctor for the correct dosage and length of treatment as it will depend on the patient’s condition and their response to the therapy. The tablets can be dangerous if it comes into contact with the skin, always swallow it whole and not crush or break the tablets.
- Erlocip-150 side effects such as:
- Mouth sores
- Weight loss
- Dry skin
- Loss of appetite
Contact a doctor immediately should Erlocip 100mg side effects persist or encounter more severe side effects such as:
- Unusual bleeding or bruising
- Persistent cough
- Mental or mood changes
- Breathing problems
- Abdominal pain
- Signs of infection
- Vision problems
When should Erlocip not be used?
You should not use Erlocip cipla tablets if you:
- are allergic to erlotinib or any ingredients in Erlocip
- are pregnant or are breastfeeding
- have kidney or liver disease
- are having immunisation with live vaccine
- use contact lenses and/or have a history of eye problems
- have gastrointestinal problems particularly diarrhoea as this can worsen with Erlocip
- have prior history of peptic ulceration or diverticular disease as this can increase risk of gastrointestinal perforation
- are a smoker
- have interstitial lung disease
are taking medicines that interact with Erlocip cipla, including corticosteroids and NSAIDs for pain and inflammation, statins for high cholesterol, anticoagulants like warfarin, the immunosuppressant cyclosporine, verapamil for hypertension, proton pump inhibitors like omeprazole, antifungals like ketoconazole, antibiotics like ciprofloxacin, erythromycin, clarithromycin, rifampicin
Missed dose of Erlocip
If you miss a dose of erlocip 150mg uses take it as soon as you remember, unless it is time to take the next dose, then skip the missed dose. Do not take a double dose.
How should Erlocip be stored?
You should store your Erlocip below 25°C in a cool dry place.
Buy Related Medicine :